Point Of Care Diagnostics and Testing Market Size Worth $35.74 Billion By 2028 Due To Rising Number of Cases of Cardiovascular Disorders, Diabetic And HIV Patients | Million Insights

 Breaking News
  • No posts were found

Point Of Care Diagnostics and Testing Market Size Worth $35.74 Billion By 2028 Due To Rising Number of Cases of Cardiovascular Disorders, Diabetic And HIV Patients | Million Insights

September 17
14:12 2021
Point Of Care Diagnostics and Testing Market Size Worth $35.74 Billion By 2028 Due To Rising Number of Cases of Cardiovascular Disorders, Diabetic And HIV Patients | Million Insights
Million Insights – World’s Fastest Growing Market Research Database
According to new report available with Million Insights, the global point of care (POC) diagnostics & testing industry report provides a detailed evaluation of the industry by highlighting information on different aspects which include drivers, restraints, growth opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

As per the published report, the global Point Of Care (POC) Diagnostics And Testing Market size is estimated to arrive at USD 35.74 billion by 2028. It is projected to develop by 3.25% CAGR in the period of the forecast.

Point of care diagnostics has considerably changed the remedial patterns, useful for the treatment of the patients suffering with Cardiovascular Disorders (CVDs), diabetic patients and HIV patients, during the most recent days. Besides, rising improvements on the scope are expected to improve the medication workflows for cancer, transmittable illness as well as strokes.

To download the sample pdf of Point Of Care (POC) Diagnostics And Testing Market Report “Please” click here https://www.millioninsights.com/industry-reports/point-of-care-poc-diagnostics-testing-market/request-sample

canada-point-of-care-diagnostics-testing-market

The industry is positioned to observe, well-paid development, since point of care diagnostics provides a cost-effective option for the time-honored laboratory examination. Point-of-care apparatuses are intended to present information at the site and moment of patient treatment. This facilitates first diagnosis of the illness.

The implementation of telemedicine in distant patient examination, miniaturized technology, incessant POCT and the introduction of minimally invasive & non-invasive point of care diagnostics apparatuses, are some of the important things encouraging the expansion of the point of care diagnostics & testing market.

To browse report summary & detailed TOC, “please” click the link below:  https://www.millioninsights.com/industry-reports/point-of-care-poc-diagnostics-testing-market

global-point-of-care-diagnostics-testing-market

Further key findings from the report suggest:

• North America was the most important provincial market, and it retained above 34% revenue share in 2020. The region was led by the U.S.

• In March 2020, the initial point of care diagnostics test for COVID-19 was accepted by the U.S. FDA, beneath Emergency Use Authorization. This was produced by Cepheid. The major companies of this market are busy in improving and creating such type of tests, which sequentially increasing the expansion of the subdivision.

• The sector for infectious disease products is estimated to hold the maximum share of revenue by 2028. Mainly, this enlargement is credited to the worldwide COVID-19 pandemic. 

• Due to the rising changeover from traditional lab test to point of care diagnostics by healthcare experts, to curtail the time in use for analysis and more actions, the clinics end-use segment retained the leading share of revenue in 2020. It is expected to further develop by a stable CAGR for the duration of the forecast.

• Owing to the soaring demand for the point of care diagnostics glucose monitors, for regular testing of glucose level of the diabetic patients, caused by the augmented figure of diabetic patients through the world, the glucose testing product sector headed the market in 2020.

Million Insights segmented the global POC diagnostics & testing market based on End Use, Product and Region.

POC Diagnostics & Testing Product Outlook (Revenue, USD Million, 2017 – 2028)

    • Glucose Testing

    • Hb1Ac Testing

    • Coagulation

    • Fertility

    • Infectious Diseases

        • HIV

        • Clostridium Difficile

        • HBV

        • Pneumonia or Streptococcus Associated Infections

        • Respiratory Syncytial Virus (RSV)

        • HPV

        • Influenza/Flu

        • HCV

        • MRSA

        • TB and Drug-Resistant TB

        • HSV

        • COVID-19

        • Other Infectious Diseases

    • Cardiac Markers

    • Thyroid Stimulating Hormone

    • Hematology

    • Primary Care Systems

    • Decentralized Clinical Chemistry

    • Feces

    • Lipid Testing

    • Cancer Marker

    • Blood Gas/Electrolytes

    • Ambulatory Chemistry

    • Drug Abuse Testing

    • Urinalysis

POC Diagnostics & Testing End-use Outlook (Revenue, USD Million, 2017 – 2028)

    • Clinics

        • Pharmacy & Retail Clinics

        • Physician Office

        • Urgent Care Clinics

        • Non-practice Clinics

    • Hospitals

    • Home

    • Assisted Living Healthcare Facilities

    • Laboratory

POC Diagnostics & Testing Regional Outlook (Revenue, USD Million, 2017 – 2028)

    • North America

        • U.S.

        • Canada

    • Europe

        • Germany

        • U.K.

        • France

        • Italy

        • Spain

        • Russia

    • Asia Pacific

        • Japan

        • China

        • India

        • Australia

        • Korea

    • Latin America

        • Brazil

        • Mexico

    • Middle East & Africa (MEA)

        • South Africa

        • Saudi Arabia

Companies 

Various companies for point of care diagnostics and testing market are:

    • Spectral Medical, Inc.

    • Orasure Technologies, Inc.

    • Trinity Biotech

    • Trividia Health, Inc.

    • Instrumentation Laboratory

    • Siemens Healthcare AG

    • Biomerieux SA

    • Danaher Corp.

    • F. Hoffmann-La Roche Ltd.

    • Nipro Corp.

    • Sekisui Diagnostics

    • Quidel Corp.

    • Nova Biomedical

    • Zoetis, Inc.

    • Abbott Laboratories

    • Becton Dickinson (BD)

    • Qiagen

Read the Latest Market Research Reports by Million Insights:

• Cosmetic Dentistry Market: The global cosmetic dentistry market was prized by USD 6.9 billion in 2020. It is estimated to witness a 5.0% CAGR from 2021 to 2028.

• Hormone Replacement Therapy Market: The global hormone replacement therapy market was prized by USD 21.8 billion in 2019. It is estimated to witness 7.7% CAGR from 2020 to 2027.

About Million Insights

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email: Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India
Website: https://www.millioninsights.com/industry-reports/point-of-care-poc-diagnostics-testing-market